ADRF

Asbestos Diseases Research Foundation

ABN 79 121 168 867

The Asbestos Diseases Research Foundation (ADRF) was established in 2006 as a charitable, not-for-profit organisation dedicated to assist and support the research efforts into asbestos and other dust-related diseases. The Foundation established and operates the Asbestos Diseases Research Institute (ADRI) a dedicated research institute. The ADRF continues to support ADRI by attracting financial support from companies and individuals.

Objectives

The objects for which the Foundation is established are:

  1. to promote, sponsor and facilitate research and healthcare delivery among those individuals and communities exposed to asbestos or other dusts or suffering from asbestos-related or other dust-related diseases;
  2. to provide leadership and excellence in asbestos-related and dust-related diseases research activities;
  3. to promote awareness of the special circumstances experienced by those exposed to asbestos or other dusts which can lead to potential or actual asbestos-related or other dust-related diseases;
  4. to promote, sponsor and facilitate asbestos-related and dust-related diseases education and training in relevant health disciplines;
  5. to further knowledge of medicine and science by promoting the conduct of research in the field of asbestos-related and other dust-related diseases;
  6. to achieve a better understanding of the nature and causes of asbestos-related and dust-related human diseases and afflictions;
  7. to improve methods of preventing, diagnosing and treating those diseases and afflictions; and
  8. where possible, to apply its research and other activities, either directly or indirectly, to the development of relevant products and treatments; preventative strategies and practices; and educational programs and materials for asbestos-related and other dust-related diseases.


The Foundation must pursue its objectives principally in Australia.

Further information on governance and board members is available on the ADRI website:

ADRI